Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. (Q53227029)
Jump to navigation
Jump to search
scientific article published on 11 September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. |
scientific article published on 11 September 2006 |
Statements
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG. (English)
Ignace Vergote
Jacobus Pfisterer
Marie Plante
Andreas du Bois
Hal Hirte
Angel J Lacave
Uwe Wagner
Anne Stähle
Gavin Stuart
Rainer Kimmig
Sigrid Olbricht
Tien Le
Janusz Emerich
Walther Kuhn
James Bentley
Christian Jackisch
Hans-Joachim Lück
Justine Rochon
Annamaria Hayden Zimmermann
Elizabeth Eisenhauer
AGO-OVAR
NCIC CTG
EORTC GCG
11 September 2006
24
29
4699-4707